ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

BNP PARIBAS ARBITRAGE, SA's Holding History (CIK: 0001166588)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 17,318,000 Value ($000) $25,463 Avg Close — Range —
Q3 2025
Shares 25,078,000 Value ($000) $41,216 Avg Close — Range —
Q2 2025
Shares 16,498,000 Value ($000) $21,451 Avg Close — Range —
Q1 2025
Shares 5,542,000 Value ($000) $6,382 Avg Close — Range —